Ultibro Breezhaler

Ultibro Breezhaler Indications/Uses

indacaterol + glycopyrronium

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
Ultibro Breezhaler is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms and reduce exacerbations in adult patients with chronic obstructive pulmonary disease (COPD).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in